Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$501K Buy
68,793
+10,936
+19% +$99K ﹤0.01% 1308
2025
Q4
$557K Sell
57,857
-3,311
-5% -$34.3K ﹤0.01% 1281
2025
Q3
$746K Buy
61,168
+24,579
+67% +$258K ﹤0.01% 1123
2025
Q2
$292K Sell
36,589
-1,872
-5% -$13.1K ﹤0.01% 1411
2025
Q1
$279K Buy
+38,461
New +$280K ﹤0.01% 1219
2024
Q3
Sell
-14,948
Closed -$158K 1187
2024
Q2
$158K Sell
14,948
-9,829
-40% -$125K ﹤0.01% 928
2024
Q1
$343K Buy
+24,777
New +$387K ﹤0.01% 735

Other funds holding NUS

IEQ Capital's NUS Position: Q1 2026 in Review

IEQ Capital increased its Nu Skin (NUS) stake by 19% in Q1 2026, buying an estimated $99K and bringing the position to 68,793 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #1308.

IEQ Capital first reported a position in NUS in Q1 2024 and has held it in 7 quarters since. The position peaked at $746K in Q3 2025. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • IEQ Capital held 68,793 shares of Nu Skin worth $501K as of Q1 2026.
  • IEQ Capital bought 10,936 Nu Skin shares in Q1 2026, an estimated $99K.
  • Nu Skin made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1308 holding.
  • IEQ Capital first reported a position in Nu Skin in Q1 2024 and has held it in 7 quarters since.
  • IEQ Capital's Nu Skin position peaked at $746K in Q3 2025.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.